TITLE

COMMENTARY: Review: Anti-tumor necrosis factor antibody therapy for rheumatoid arthritis increases risk for serious infection and malignancy

AUTHOR(S)
Shoor, Stanford
PUB. DATE
November 2006
SOURCE
ACP Journal Club;Nov/Dec2006, Vol. 145 Issue 3, p65
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents the author's comments on a medical study on anti-tumor necrosis factor (anti-TNF) antibody therapy for rheumatoid arthritis. The study revealed that the antibody therapy for rheumatoid arthritis increases risk for serious infection and malignancy. But the author says that study patients and coexistence of an already altered host immune system have made it difficult to prove such occurrences and to ascribe them to the treatment or the underlying disease.
ACCESSION #
23245691

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics